Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Maxacalcitol, also known as 22-oxacalcitriol or OCT, is the third synthetic vitamin D analog after paricalcitol and doxercalciferol. It is a vitamin D3 derivative with an oxygen atom in the 22-position as its main structural feature. Maxacalcitol is a vitamin D receptor agonist that has a strong inhibitory effect on the synthesis and secretion of parathyroid hormone in cases of severe parathyroid hyperplasia. Unlike other agents, it induces only minor effects on calcium and phosphate metabolism, making it a safer alternative for treating secondary hyperparathyroidism (SHPT) associated with chronic renal failure.

103909-75-7

Post Buying Request

103909-75-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103909-75-7 Usage

Uses

Used in Pharmaceutical Industry:
Maxacalcitol is used as a treatment for secondary hyperparathyroidism (SHPT) associated with chronic renal failure. It is effective in suppressing parathyroid hormone synthesis and secretion, making it a valuable option for managing this condition.
Used in Renal Care:
Maxacalcitol is used as a therapeutic agent for patients with chronic renal failure who suffer from SHPT. Its ability to inhibit parathyroid hormone synthesis and secretion without causing hypercalcemia and hyperphosphatemia makes it a safer choice for these patients.
Brand Names:
Maxacalcitol is marketed under the brand names Prezios (Chugai Pharmaceutical Co., Ltd., Japan) and Oxarol.

Originator

Chugai (Japan)

Check Digit Verification of cas no

The CAS Registry Mumber 103909-75-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,9,0 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 103909-75:
(8*1)+(7*0)+(6*3)+(5*9)+(4*0)+(3*9)+(2*7)+(1*5)=117
117 % 10 = 7
So 103909-75-7 is a valid CAS Registry Number.
InChI:InChI=1/C26H42O4/c1-17-20(15-21(27)16-24(17)28)9-8-19-7-6-12-26(5)22(10-11-23(19)26)18(2)30-14-13-25(3,4)29/h8-9,18,21-24,27-29H,1,6-7,10-16H2,2-5H3/b19-8+,20-9-/t18-,21+,22+,23-,24-,26+/m0/s1

103909-75-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Maxacalcitol

1.2 Other means of identification

Product number -
Other names 22-Oxacalcitriol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103909-75-7 SDS

103909-75-7Relevant articles and documents

Improved and efficient synthesis of Maxacalcitol

Feng, Shi,Cui, Li-Fei,Wei, He-Geng,Zheng, Guo-Jun,Wang, Ya-Ping,Wang, Xiang-Jing,Zhang, Ji,Xiang, Wen-Sheng

, p. 771 - 774 (2014)

Maxacalcitol, the 22-oxa-derivative of 1α, 25-dihydroxyvitamin D 3, has been used as an antihyperparathyroidism and antipsoriatic drug. In this paper, an alternative synthetic route has been developed using commercially available vitamin D

Synthesis of tritiated 1α,25-dihydroxy-22-oxavitamin D3

Watanabe,Akiyama,Kawanishi,Kubodera

, p. 645 - 654 (1995)

Synthesis of two tritiated 1α,25-dihydloxy-22-oxavitamin D3 (OCT), [26-3H3]OCT (3) and [2β-3H]OCT (4), is described. [26-3H3]OCT (3) was prepared by tritiation at the side chain with tritia

Stereoselective synthesis of 22-oxacalcitriol (OCT) and analogues modified at C25

Fall, Yagamare,González, Victoria,Vidal, Beatriz,Mouri?o, Antonio

, p. 427 - 429 (2002)

The stereoselective synthesis of 22-oxacalcitriol (OCT) has been achieved. The triene system was introduced using the Lythgoe-Hoffmann La Roche convergent Wittig-Horner approach to couple ketoester 7 with A ring phosphine oxide 8. The value of the resulting ester 6 for synthesis of C25-modified OCT analogues is exemplified by the synthesis of 5.

A MARTHA calciferol preparation method (by machine translation)

-

, (2017/11/04)

The invention belongs to the field of pharmaceutical chemistry, and in particular relates to a preparation method of MARTHA calciferol. The method as the compound 1 as the starting material, through the tosylates selective protection secondary hydroxy, under the action of alkali, in methanol occurs in the intramolecular cyclization reaction to produce the compound 3, 3 through the alkene third oxidation, selective protection secondary hydroxy to obtain compound 5, compound 5 in opened under the effect of triatomic acid to obtain compound 6, compound 6 deprotected base to obtain the target compound. The invention raw materials are easy, simple operation, the step is short, only 6 step reaction. (by machine translation)

SYNTHETIC INTERMEDIATE OF MAXACALCITOL, PREPARATION METHOD THEREFOR AND USE THEREOF

-

Paragraph 0121; 0122; 0123; 0124, (2016/09/26)

The present invention provides a new method for synthesizing maxacalcitol and an intermediate thereof. According to the method, the maxacalcitol is creatively synthesized through the steps of: taking vitamin D2 as an initial raw material, obtaining a compound represented by formula II, oxidizing, chirally reducing, grafting with a side chain, introducing a hydroxyl group on the C-1 position, and photochemically overturning.

Industrial synthesis of maxacalcitol, the antihyperparathyroidism and antipsoriatic vitamin D3 analogue exhibiting low calcemic activity

Shimizu, Hitoshi,Shimizu, Kazuki,Kubodera, Noboru,Mikami, Tetsuhiro,Tsuzaki, Kaname,Suwa, Hiroyuki,Harada, Koji,Hiraide, Akira,Shimizu, Motoki,Koyama, Kaichiro,Ichikawa, Yoshihide,Hirasawa, Daisuke,Kito, Yasushi,Kobayashi, Mio,Kigawa, Masaharu,Kato, Masahiro,Kozono, Toshiro,Tanaka, Hideki,Tanabe, Makoto,Iguchi, Masanori,Yoshida, Mitsutaka

, p. 278 - 287 (2012/12/24)

Maxacalcitol, the 22-oxa-derivative of 1α,25-dihydroxyvitamin D 3 and used currently as an antihyperparathyroidism and antipsoriatic drug, has been synthesized in seven chemical steps from 1α- hydroxydehydroepiandrosterone on the basis of our previously developed route. The present synthesis allows the production of the protected form of the penultimate intermediate in 26% overall yield in a kilogram scale reaction employing neither difficult reaction conditions nor chromatographic purification, having overcome all the difficulties involved in the previous route.

Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same

-

Page 9, (2008/06/13)

Disclosed herein are an ultraviolet irradiation apparatus for photochemical reactions which can irradiate the photo-reactive solution with ultraviolet rays having a specific wavelength suitable for the intended photochemical reaction at a high efficiency, and a process by which a provitamin D derivative can be converted into a provitamin D derivative at a high efficiency by means of a photochemical reaction by one-step process of light irradiation, thereby preparing a vitamin D derivative at a high efficiency. The ultraviolet irradiation apparatus irradiates the photo-reactive solution with the ultraviolet rays having the specific wavelength through a quartz rod. Specifically, the apparatus is constructed by an electric discharge lamp, a condensing and reflecting mirror and a plane mirror both having wavelength selective property, an optical filter which transmits the ultraviolet rays having the specific wavelength, and a quartz rod on which the ultraviolet rays having the specific wavelength are struck. The photo-reactive solution is irradiated with the ultraviolet rays from the quartz rod. The quartz rod is immersed in the photo-reactive solution, or a reaction vessel is irradiated with the ultraviolet rays from the quartz rod. In the preparation process of the vitamin D derivative, an ultraviolet irradiation apparatus for photochemical reactions having an ultraviolet radiation-emitting lamp, an optical system having wavelength selective property and a quartz rod on which the ultraviolet rays having the specific wavelength from the optical system are struck is used, and a solution of a provitamin D derivative is irradiated with the ultraviolet rays having the specific wavelength emitted from the quartz rod to cause a photochemical reaction of the provitamin D derivative solution, thereby forming a previtamin D derivative. The previtamin D derivative is further subjected to a thermal isomerization reaction to prepare the vitamin D derivative.

Synthetic studies of vitamin D analogues. XI. Synthesis and differentiation-inducing activity of 1α-25-dihydroxy-22-oxavitamin D3 analogues

Kubodera,Watanabe,Kawanishi,Matsumoto

, p. 1494 - 1499 (2007/10/02)

Six analogues of 1α,25-dihydroxy-22-oxavitamin D3 (OCT) (2), 26,27-dimethyl OCT (5), 26,27-diethyl OCT (6), 24-norOCT (7), 24-homoOCT (8), 24-dihomoOCT (9), and 24-trihomoOCT (10) were synthesized from the 20(S)-alcohol (11) as the common start

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 103909-75-7